Search For

Impact of metabolic reprogramming on the immune response in hepatocellular carcinoma

Yttrium-90 combination therapies in hepatocellular carcinoma: current evidence and future directions

Patient-derived tumor organoid models for functional precision oncology in hepatocellular carcinoma

Resistance to immune checkpoint inhibitors in hepatocellular carcinoma: mechanisms and combination strategies to overcome it

Histone lactylation in hepatocellular carcinoma: a key epigenetic hub linking metabolic reprogramming and the immune microenvironment

Multi-task neural network enhanced by data augmentation and ROI optimization for prognosis and MVI prediction in HCC using contrast-enhanced CT

Review of advances in FOLFOX-HAIC for conversion, neoadjuvant, and adjuvant therapy in hepatocellular carcinoma

Kupffer cells and monocyte-derived macrophages in the pathogenesis and treatment of hepatocellular carcinoma

The role of “treatment unfeasibility” in the multiparametric, multidisciplinary, and expert evaluation of HCC patients

Metabolic reprogramming and the tumor microenvironment in hepatocellular carcinoma: mechanisms and therapeutic targeting

The evolving role of contrast-enhanced ultrasound in hepatocellular carcinoma: from diagnosis to therapeutic monitoring

Converse therapeutic hierarchy in hepatocellular carcinoma